Characteristic | No. (%) of patients* | |||
---|---|---|---|---|
Overall n = 727 | HCV ever-treated and treatment-naïve subgroups n = 542 | HCV ever-treated n = 255 | HCV treatment-naive n = 287 | |
HCV treatment status | ||||
Treated successfully | 188 (25.9) | 188 (34.6) | 188 (73.7) | 0 (0) |
Being treated currently | 27 (3.7) | 27 (5.0) | 27 (10.6) | 0 (0) |
Failed treatment | 20 (2.8) | 20 (3.7) | 20 (7.8) | 0 (0) |
Did not complete treatment | 3 (0.4) | 3 (0.6) | 3 (1.2) | 0 (0) |
Completed treatment, success unknown | 17 (2.3) | 17 (3.1) | 17 (6.7) | 0 (0) |
Treatment-naïve | 287 (39.4) | 287 (53.0) | 0 (0) | 287 (100) |
HCV cleared without treatment | 124 (17.1) | – | – | – |
Unknown | 61 (8.4) | – | – | – |
Male | 515 (70.8) | 403 (74.4) | 202 (79.3) | 201 (70.0) |
Age (continuous), median (IQR) | 54 (46–61) | 55 (47–61) | 56 (50–62) | 53 (45–60) |
Age (categorical), yr | ||||
≤ 45 | 177 (24.3) | 116 (21.4) | 40 (15.7) | 76 (26.5) |
46–65 | 465 (64.0) | 364 (67.2) | 176 (69.1) | 188 (65.5) |
> 65 | 85 (11.7) | 62 (11.4) | 39 (15.2) | 23 (8.0) |
HIV | 139 (19.1) | 108 (19.9) | 55 (21.6) | 53 (18.5) |
Diabetes type 2 | 69 (9.5) | 57 (10.5) | 29 (11.4) | 28 (9.8) |
History of intravenous drug use | 317 (43.6) | 259 (47.8) | 101 (39.6) | 158 (55.1) |
Ever homeless or shelter or underhoused | 98 (13.5) | 81 (14.9) | 25 (9.8) | 56 (19.5) |
Note: HCV = hepatitis C virus, IQR = interquartile range.
↵* Unless otherwise specified.